Page last updated: 2024-11-05

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Inflammatory Bowel Diseases

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole has been researched along with Inflammatory Bowel Diseases in 1 studies

3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole: antineoplastic; activates platelet guanylate cyclase; a radiosensitizing agent and guanylate cyclase activator; structure in first source
lificiguat : A member of the class of indazoles that is 1H-indazole which is substituted by a benzyl group at position 1 and a 5-(hydroxymethyl)-2-furyl group at position 3. It is an activator of soluble guanylate cyclase and inhibits platelet aggregation.

Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Subbaramaiah, K1
Yoshimatsu, K1
Scherl, E1
Das, KM1
Glazier, KD1
Golijanin, D1
Soslow, RA1
Tanabe, T1
Naraba, H1
Dannenberg, AJ1

Other Studies

1 other study available for 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole and Inflammatory Bowel Diseases

ArticleYear
Microsomal prostaglandin E synthase-1 is overexpressed in inflammatory bowel disease. Evidence for involvement of the transcription factor Egr-1.
    The Journal of biological chemistry, 2004, Mar-26, Volume: 279, Issue:13

    Topics: Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cells, Cultured; Colon; DNA-Binding Protein

2004